Navigation Links
Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
Date:7/6/2009

ng dynamics between ErbB2 and ErbB3 and to exquisitely target cancer cells."

MM-111 has two antibody arms; a targeting arm that binds to ErbB2 with high affinity and a therapeutic arm that binds to ErbB3 (also known as HER3). Both ErbB2 and ErbB3 are members of the ErbB family of receptors, a complex molecular network whose activation is commonly linked with cancer. In 2003, Merrimack researchers identified ErbB3 as a highly sensitive node in the ErbB signaling network and also found it played a dominant role in activation of the PI3 kinase pathway - a pathway believed to be used by cancer cells to sustain survival. The importance of ErbB3 in cancer progression is now widely appreciated. Preclinical data demonstrating the impact of MM-111 in multiple cancer models were presented at the annual meeting of the American Association for Cancer Research in April.

The current Phase 1/2 study will evaluate the human safety and pharmacokinetics (PK) of MM-111. The Phase 1 portion of the study is enrolling patients with tumors that overexpress ErbB2 while the Phase 2 portion of the study will be restricted to ErbB2 overexpressing (HER2+) breast cancer patients. The first dose was administered at South Texas Accelerated Research Therapeutics (START) where enrollment is currently underway. Fox Chase Cancer Center is expected to participate in the trial this July.

"MM-111 has the potential to help patients who are resistant to currently approved ErbB2 therapies," said William J. Slichenmyer, MD, Senior Vice President and Chief Medical Officer at Merrimack. "Preclinical studies of MM-111 have demonstrated that the bispecific approach shows antitumor activity in a wid
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
2. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
3. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
4. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
5. Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
6. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
7. Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. The Crohns & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
10. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
11. DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
(Date:7/31/2014)... According to a report by Fox ... knee replacement surgery on his left knee. This follows partial ... The story also reports that Bush was able to ride ... back on the bike again soon. This high level of ... knee replacement. , “Partial knee replacements give patients the ...
(Date:7/31/2014)... Hills, NY (PRWEB) July 31, 2014 ... Kim as its new board-certified plastic surgeon! , ... with helping men and women achieve the look of ... through his top procedures: breast augmentation (including ... breast or buttocks (also known as Brazilian butt lift), ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The shale ... to the top of current U.S. natural gas production ... a “boom and bust” cycle, similar to previous resource ... study released today by Washington & Jefferson College’s (W&J) ... Environmental Law Institute (ELI) confirms that the gas boom ...
(Date:7/31/2014)... Some pain relief medications can be as addictive as ... day, 46 people in the U.S. die from legal pain ... admitted to an emergency room because of opioid complications. ... of prescription and over-the-counter painkillers and is calling on the ... make these drugs safer. , The full report, “Deadly Pain ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Staying happy ... be tricky at best. Men and women get sucked into ... wives, life partners, and taxi services to kids. , ... offers her "3 Fast + Fun Ways to Reignite the ... download . , “This is a much better path ...
Breaking Medicine News(10 mins):Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:Bellava MedAesthetics Welcomes Dr. Chang Soo Kim as Its New Westchester Plastic Surgeon 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 3Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 3Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3
... University of Leicester have opened up a whole new ... anti-cancer drug targets, thanks to a completely new and ... Watson, Fairall and Santos, have published their research this ... a new understanding of how transcriptional repression complexes work. ...
... at Oregon State University provides evidence for the first time ... in many animals can clearly cause accelerated neurodegeneration, loss ... published in Neurobiology of Disease and done by ... to this, it wasn,t clear which came first - whether ...
... 10 (HealthDay News) -- A drug commonly used to treat ... for people older than 40 years who have Down syndrome ... Although previous animal studies of the Alzheimer,s drug, memantine, showed ... of people with Down syndrome aged 40 and older revealed ...
... (AKI) has severe consequences, with a 25 to 80 percent ... diagnose AKI using a urine test, enabling emergency departments to ... hospital. The study will be published online on January 9, ... Cardiology. Physicians typically measure a patient,s creatinine levels ...
... risk of suffering a heart attack increases by approximately 21 ... one, according to a study lead by researchers at Beth ... 9 online in the journal Circulation found the ... the first week after the death of a loved one, ...
... Maureen Salamon HealthDay Reporter , MONDAY, Jan. 9 ... migraine patients as three types of traditional acupuncture, a new ... four groups at nine Chinese hospitals -- one sham acupuncture ... of researchers, including Dr. Fan-rong Liang at Chengdu University in ...
Cached Medicine News:Health News:Unexpected discovery opens up new opportunities for targeting cancer 2Health News:Disruption of biological clocks causes neurodegeneration, early death 2Health News:Alzheimer's Med Seems Ineffective in Those With Down Syndrome 2Health News:Biomarkers identify acute kidney injury in emergency patients 2Health News:Heart attack risk rises after loss of loved one 2Health News:Power of Acupuncture to Ease Migraines Questioned in Study 2Health News:Power of Acupuncture to Ease Migraines Questioned in Study 3
(Date:7/31/2014)... , July 31, 2014 Marken announced today ... facilities to meet the clinical trial logistics growth in ... newly expanded facility will continue to serve as a ... to and from the region, and will provide additional ... Marken will combine its office and warehouse into a ...
(Date:7/31/2014)... 2014 De Pfizer Clinical Research Unit (PCRU) ... vrijwilligers van Japanse komaf voor medewerking aan klinisch onderzoek. ... is één van twee onderzoekseenheden van Pfizer , ... verbeteren door de ontdekking en ontwikkeling van nieuwe medicijnen. ... naar mannen en vrouwen van Japanse komaf – leeftijd ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... purchasing contract with Premier will end on September ... GPO will be able to continue their relationship ... HPA, MedAssets, Novation, and ROi, in addition to ... with Cepheid. "Cepheid has always recognized ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
... The primary objective of the BioPro Toe ... that will relieve pain and restore motion ... foot undisturbed. The procedure used to implant ... bone resection. , ,The design for the ...
... Electrodes provide direct cranial nerve monitoring ... circumferential design provides sensitive contact on ... real-time recordings. This unique approach provides ... removal of acoustic neuromas, microvascular decompressions, ...
... Ad-Techs Intraoperative Electrodes share similar ... The main difference is that ... are numbered to assist you ... are designed for use with ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
Medicine Products: